The US stock market outlook remains optimistic with a target of 8,000 for the S&P 500 by the end of the year, driven by AI-related business investments that counterbalance high interest rates and weak macroeconomic conditions. However, recent calls from major AI CEOs for regulatory measures reflect concerns over open-source competition and rising capital expenditures rather than purely altruistic motives. Investors should anticipate increased market volatility due to ongoing debates about AI regulation, energy supply disruptions, and potential interest rate hikes.
The request from AI CEOs for regulatory measures is the subject, with Pluang's market breadth showing 44 stocks rising and 106 falling among 150 US stocks tradable on the platform. For readers following this, here is Pluang's market snapshot as of Sep 16, 2026 02:51 WIB: HOOD (Robinhood Markets, Inc.) declined by 3.88% to USD 109.89, QCOM (QUALCOMM, Inc.) rose by 3.88% to USD 187.14, and NVAX (Novavax Inc) dropped by 3.81% to USD 9.22.
Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...
ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...
Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...
eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...
Balchem Corporation reported strong Q3 2026 results with net sales of $290.7 million, up 8.6% year-over-year, and net earnings of $46.7 million, a 16% increase. Growth was driven by all three segments: Human Nutrition and Health, Animal Nutrition and...
